News - Vaccines, Antibiotics and Infectious diseases

Filter

Popular Filters

Positive top-line results for Pfizer’s Prevenar 13 in pneumonia in over 65s

25-02-2014

US pharma behemoth Pfizer says that top-line results from a study of Prevenar 13 (pneumococcal 13-valent…

Antibiotics and Infectious diseasesPfizerPharmaceuticalPrevenarResearchVaccines

Valneva initiates fourth antibody discovery program for Sanofi Pasteur

25-02-2014

European biotechnology company Valneva has initiated a fourth monoclonal antibody discovery program for…

Antibiotics and Infectious diseasesBiotechnologyLicensingResearchSanofiSanofi PasteurVaccinesValneva

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted

03-01-2014

China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

ProJect Pharma and TUM-spin-off link on H. pylori vaccine development

02-12-2013

Germany-based ProJect Pharmaceutics has signed a development agreement with ImevaX, a spin-off project…

Antibiotics and Infectious diseasesImevaXLicensingPharmaceuticalProJect PharmaceuticsResearchVaccines

Infectious disease treatments market driven by growth in middle-income to low-income countries

17-05-2013

The infectious disease treatments market increased at a compound annual growth rate (CAGR) of 6.9% between…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalVaccines

GlaxoSmithKline and Abbott to start production in Ukraine

19-03-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

Riboxx Pharma links with China National Biotec to evaluate Riboxxim as adjuvant in a vaccine

05-03-2013

Germany's Riboxx Pharmaceuticals GmbH and China National Biotec Group (CNBG) say they have initiated…

Antibiotics and Infectious diseasesChina National BiotecPharmaceuticalResearchRiboxx PharmaceuticalsRiboxximVaccines

NeRRe Therapeutics created to develop NRAs from GSK; GlycoVaxyn deal with GSK

20-12-2012

NeRRe Therapeutics was launched in the UK yesterday to develop a portfolio of clinical and pre-clinical…

Antibiotics and Infectious diseasesBiotechnologyFinancialGlaxoSmithKlineGlycoVaxynLicensingNeRReTherapeuticsNeurologicalNovo NordiskPharmaceuticalResearchVaccines

Further initiatives from GlaxoSmithKline to help tackle global health challenges; TB deal with Aeras

12-10-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday announced new measures to further advance its commitment…

Antibiotics and Infectious diseasesGlaxoSmithKlineGlobalHealthcarePharmaceuticalResearchVaccines

Single silk device can store and deliver vaccine or antibiotic without costly cold chain

10-07-2012

Researchers at the USA-based Tufts University School of Engineering have discovered a way to maintain…

Antibiotics and Infectious diseasesPharmaceuticalResearchVaccines

Daiichi Sankyo and Terumo link up for vaccine development

27-02-2012

Drug major Daiichi Sankyo (TYO: 4568) and fellow Japanese company Terumo Corp (TYO: 4543) have entered…

Antibiotics and Infectious diseasesDaiichi SankyoPharmaceuticalResearchTerumoVaccines

Sanofi Pasteur and CureVac collaborate on a $33.1 million project on vaccines for infectious diseases

16-11-2011

Germany’s CureVac says it has signed several agreements with Sanofi Pasteur, the vaccines division…

Antibiotics and Infectious diseasesBiotechnologyCureVacLicensingPharmaceuticalResearchSanofiSanofi PasteurVaccines

GlaxoSmithKline warned by US FDA over cGMP violations at UK plant; positive malaria vaccine news

20-10-2011

UK pharma giant GlaxoSmithKline ILSE: GSK) has received a warning letter from the US Food and Drug Administration…

Antibiotics and Infectious diseasesGlaxoSmithKlinePharmaceuticalRegulationResearchVaccines

Back to top